|
ITSN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.03659986045091E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.96329999988276E-07 |
| Normal-vs-Stage2 |
1.03760000003117E-06 |
| Normal-vs-Stage3 |
6.85279610834755E-11 |
| Normal-vs-Stage4 |
6.79190004237995E-09 |
| Stage1-vs-Stage2 |
2.631700E-02 |
| Stage1-vs-Stage3 |
2.242300E-03 |
| Stage1-vs-Stage4 |
7.220500E-03 |
| Stage2-vs-Stage3 |
9.448600E-01 |
| Stage2-vs-Stage4 |
8.300400E-01 |
| Stage3-vs-Stage4 |
7.017600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.55229981383343E-10 |
| Normal-vs-AfricanAmerican |
1.836470E-03 |
| Normal-vs-Asian |
4.25390000002857E-07 |
| Caucasian-vs-AfricanAmerican |
5.481000E-01 |
| Caucasian-vs-Asian |
7.584200E-01 |
| AfricanAmerican-vs-Asian |
4.231600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99630000997342E-09 |
| Normal-vs-Female |
2.10810002787554E-09 |
| Male-vs-Female |
6.889000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.14589999999459E-05 |
| Normal-vs-Age(41-60Yrs) |
4.36899960654102E-10 |
| Normal-vs-Age(61-80Yrs) |
2.31119567928317E-11 |
| Normal-vs-Age(81-100Yrs) |
6.816400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.685000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.007500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.938210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.919800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.169000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.994400E-02 |
| Classical-VS-Follicular |
1.777630E-01 |
| Classical-VS-Other |
1.109010E-01 |
| Classical-VS-Normal |
2.68669999581306E-08 |
| Tall-VS-Follicular |
2.941600E-01 |
| Tall-VS-Other |
5.785800E-01 |
| Tall-VS-Normal |
4.06829999688441E-08 |
| Follicular-VS-Other |
4.112000E-01 |
| Follicular-VS-Normal |
1.26540000000563E-06 |
| Other-VS-Normal |
1.578240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.54370002839011E-09 |
| Normal-vs-N1 |
1.64440000000043E-05 |
| N0-vs-N1 |
5.267800E-01 |
|
|
